Susquehanna Fundamental Investments, LLC Syndax Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$19.71 - $24.57 $2.16 Million - $2.7 Million	109,827 New	109,827 $2.61 Billion
Q1 2023 May 16, 2023	SELL	$20.66 - $28.98 $719,711 - $1.01 Million	-34,836 Reduced 56.63%	26,678 $563,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $335,812 - $426,924	16,270 Added 35.96%	61,514 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $343,878 - $460,548	18,578 Added 69.67%	45,244 $1.09 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $395,723 - $590,651	26,666 New	26,666 $463,000

228

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.